Briefing the oncology community about the most recent developments in lung cancer therapy, Lung Cancer Annual 4 provides a review of the related literature from the last year, and delivers an update of the impact that this information will have on the day-to-day management of lung cancer patients. With editors of international standing providing informed, balanced perspectives, this new edition is of particular interest for its material on the new developments in non-small cell lung cancer and in mesothelioma, where important new drugs are being launched in some markets. A unique round-up of the latest research and practice in all aspects of the field, this well-established publication presents an important update of the rapidly changing world of lung cancer therapy.